{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:30:14Z","timestamp":1790299814003,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To systematically examine human papillomavirus (HPV) genotyping compared with qualitative high-risk HPV result during follow-up after treatment of high-grade cervical intraepithelial neoplasia (CIN), for risk estimation of posttreatment high-grade CIN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>MEDLINE, Cochrane, and ClinicalTrials.gov were searched from January 2000 to April 2019 for prospective studies of women and retrospective studies of residual specimens from women, tested using HPV assays with genotype reporting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>The primary outcome was posttreatment high-grade CIN after treatment of high-grade CIN. Risk of bias (individual study quality) was evaluated with a modified Newcastle-Ottawa Scale. Overall quality of evidence for the risk estimate outcomes was evaluated using modified GRADE methodology for observational diagnostic studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>Of the 233 identified abstracts, 33 full-text articles were retrieved, and seven studies were included in the synthesis. The risk of bias was deemed to be low. Either a positive qualitative HPV test result or a positive test result for the same genotype that was present pretreatment have a sensitivity for predicting posttreatment high-grade CIN that approaches 100%. However, the positive predictive value (PPV) for the same genotype result pretreatment and posttreatment (median 44.4%) is about double the PPV (median 22.2%) for qualitative HPV results. The PPV of a new HPV infection posttreatment approximates zero. Human papillomavirus genotyping discriminated risk of posttreatment high-grade CIN to a clinically significant degree for women after treatment procedures for high-grade CIN lesions, when same-genotype persistence was compared with new genotype infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>There is moderately high-quality evidence to support the improved clinical utility of HPV genotyping compared with qualitative HPV positivity to follow-up after treatment of high-grade CIN.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n                    <jats:p>PROSPERO: CRD42018091095.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>FUNDING SOURCE:<\/jats:title>\n                    <jats:p>Becton, Dickinson and Company, BD Life Sciences\u2014Diagnostic Systems.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000003409","type":"journal-article","created":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T18:57:33Z","timestamp":1565377053000},"page":"452-462","source":"Crossref","is-referenced-by-count":25,"title":["Human Papillomavirus Genotyping Compared With a Qualitative High-Risk Human Papillomavirus Test After Treatment of High-Grade Cervical Intraepithelial Neoplasia"],"prefix":"10.1097","volume":"134","author":[{"given":"Fabio","family":"Bottari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Passerini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P.","family":"Preti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria T.","family":"Sandri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clementina E.","family":"Cocuzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin S.","family":"Gary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey C.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"984528","DOI":"10.1155\/2015\/984528","article-title":"Long-Term clinical outcome after treatment for high-grade cervical lesions: a retrospective monoinstitutional cohort study","volume":"2015","author":"Del Mistro","year":"2015","journal-title":"Biomed Res Int"},{"issue":"5 suppl 1","key":"R2-20230711","doi-asserted-by":"crossref","first-page":"S78","DOI":"10.1097\/LGT.0b013e31828543c5","article-title":"Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management","volume":"17","author":"Katki","year":"2013","journal-title":"J Low Genit Tract Dis"},{"issue":"suppl 1","key":"R3-20230711","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/j.jcv.2015.10.008","article-title":"HPV testing in the context of post-treatment follow up (test of cure)","volume":"76","author":"Cuschieri","year":"2016","journal-title":"J Clin Virol"},{"issue":"3 suppl 1","key":"R4-20230711","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.ygyno.2005.07.033","article-title":"Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence","volume":"99","author":"Arbyn","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"suppl 5","key":"R5-20230711","doi-asserted-by":"crossref","first-page":"F88","DOI":"10.1016\/j.vaccine.2012.06.095","article-title":"Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer","volume":"30","author":"Arbyn","year":"2012","journal-title":"Vaccine"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ygyno.2012.01.015","article-title":"High-risk human papillomavirus testing versus cytology in predicting post-treatment disease in women treated for high-grade cervical disease: a systematic review and meta-analysis","volume":"125","author":"Kocken","year":"2012","journal-title":"Gynecol Oncol"},{"key":"R7-20230711","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7150\/jca.13503","article-title":"HPV-testing in follow-up of patients treated for CIN2+ lesions","volume":"7","author":"Mariani","year":"2016","journal-title":"J Cancer"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.ygyno.2006.04.016","article-title":"Pre- and post-conization high-risk HPV testing predicts residual\/recurrent disease in patients treated for CIN 2-3","volume":"103","author":"Alonso","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00006254-200407000-00024","article-title":"HPV testing and monitoring of women after treatment of CIN 3: review of the literature and meta-analysis","volume":"59","author":"Zielinski","year":"2004","journal-title":"Obstet Gynecol Surv"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"e7086","DOI":"10.1136\/bmj.e7086","article-title":"Cost effectiveness of human papillomavirus test of cure after treatment for cervical intraepithelial neoplasia in England: economic analysis from NHS Sentinel Sites Study","volume":"345","author":"Legood","year":"2012","journal-title":"BMJ"},{"key":"R11-20230711","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/j.1471-0528.2002.01554.x","article-title":"Persistent infection with human papillomavirus following the successful treatment of high grade cervical intraepithelial neoplasia","volume":"109","author":"Cruickshank","year":"2002","journal-title":"BJOG"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/aogs.12446","article-title":"Prognostic scores after surgical treatment for cervical intraepithelial neoplasia: a proposed model and possible implications for post-operative follow-up","volume":"93","author":"Andrade","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygyno.2006.10.011","article-title":"HPV16 and increased risk of recurrence after treatment for CIN","volume":"104","author":"Gok","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/jmv.21198","article-title":"Correlation of high-risk human papillomavirus genotypes persistence and risk of residual or recurrent cervical disease after surgical treatment","volume":"80","author":"Venturoli","year":"2008","journal-title":"J Med Virol"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(10)60903-8","article-title":"An international registry of systematic-review protocols","volume":"377","author":"Booth","year":"2011","journal-title":"Lancet"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/LGT.0000000000000441","article-title":"Onclarity HPV Extended genotyping in the management of CIN2+ lesions","volume":"23","author":"Bottari","year":"2019","journal-title":"J Low Genit Tract Dis"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"17.e1","DOI":"10.1016\/j.ajog.2009.01.005","article-title":"Follow-up after treatment of cervical intraepithelial neoplasia by human papillomavirus genotyping","volume":"201","author":"Brismar","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/ijc.25745","article-title":"Type-specific HPV geno-typing improves detection of recurrent high-grade cervical neoplasia after conisation","volume":"129","author":"Heymans","year":"2011","journal-title":"Int J Cancer"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jcv.2011.06.021","article-title":"Human Papillomavirus genotype testing combined with cytology as a 'test of cure' post treatment: the importance of a persistent viral infection","volume":"52","author":"Jones","year":"2011","journal-title":"J Clin Virol"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"72.e1","DOI":"10.1016\/j.ajog.2010.01.063","article-title":"Significance of human papillomavirus genotyping with high-grade cervical intraepithelial neoplasia treated by a loop electrosurgical excision procedure","volume":"203","author":"Kang","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ijc.26349","article-title":"Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment","volume":"131","author":"Kreimer","year":"2012","journal-title":"Int J Cancer"},{"key":"R26-20230711","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/jmv.23806","article-title":"Human papillomavirus type-specific persistence and recurrence after treatment for cervical dysplasia","volume":"86","author":"Soderlund-Strand","year":"2014","journal-title":"J Med Virol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/LGT.0000000000000144","article-title":"Study design algorithm","volume":"19","author":"Andrews","year":"2015","journal-title":"J Low Genit Tract Dis"},{"issue":"suppl 1","key":"R28-20230711","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76","author":"Arbyn","year":"2016","journal-title":"J Clin Virol"},{"issue":"3 suppl 1","key":"R29-20230711","first-page":"84","article-title":"hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi)","volume":"39","author":"Carozzi","year":"2015","journal-title":"Epidemiol Prev"},{"issue":"5 suppl 1","key":"R30-20230711","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"R31-20230711","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003409","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:57:18Z","timestamp":1689091038000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000003409"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000003409","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736413709.793565146","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}